NVP Associates, LLC - IMPEL NEUROPHARMA INC ownership

Back to all holdings Add to watchlist

IMPEL NEUROPHARMA INC's ticker is IMPL and the CUSIP is 45258K109. A total of 36 filers reported holding IMPEL NEUROPHARMA INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.7%.

Links
Filings
External links
Quarter-by-quarter ownership
NVP Associates, LLC ownership history of IMPEL NEUROPHARMA INC
ValueSharesWeighting
Q3 2023$1,323,195
-66.1%
3,077,1980.0%1.18%
-65.2%
Q2 2023$3,908,041
-9.3%
3,077,1980.0%3.41%
-31.2%
Q1 2023$4,308,077
-62.7%
3,077,1980.0%4.96%
-56.0%
Q4 2022$11,539,493–3,077,198–11.26%–
 Download
Other shareholders
IMPEL NEUROPHARMA INC shareholders Q4 2022
NameSharesValueWeighting ↓
NVP Associates, LLC 3,077,198$1,323,1951.18%
5AM Venture Management, LLC 2,884,791$1,240,4600.36%
venBio Partners LLC 2,759,791$1,186,7100.34%
Vivo Capital, LLC 2,884,789$1,240,4590.14%
LASRY MARC 225,874$97,1260.10%
Kohlberg Kravis Roberts & Co. L.P. 4,135,971$1,778,4680.06%
DCF Advisers, LLC 178,500$76,7550.04%
EPIQ PARTNERS, LLC 16,325$7,0200.01%
MCDONALD PARTNERS LLC 19,400$8,3420.00%
XTX Topco Ltd 21,222$9,1250.00%
View complete list of IMPEL NEUROPHARMA INC shareholders